Health-care companies rose as traders rotated into some lagging sectors.
Health-care companies rose as traders rotated into some lagging sectors.
Regeneron Pharmaceuticals shares fell sharply in premarket trading Monday after the biotechnology company reported a late-stage study failure of its fianlimab drug candidate in the skin cancer melanoma.
An American contracted Ebola while working in the Democratic Republic of Congo, where the outbreak of the fatal virus is spreading.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
Frank Holland breaks down what traders are watching ahead of the new session.
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
Health care stocks flashing warning for momentum investors. RSI measures stock strength, overbought when above 70. AVNS +127%…
Nishant Pant breaks down this bull call spread.
Health care is going to resume its rightful place in big-time managers' portfolios.
U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Monday.
